Kiyici, S. Et Al. 2019. Even Short-Term Telmisartan Treatment Ameliorated Insulin Resistance But Had No Influence on Serum Adiponectin and Tumor Necrosis Factor-Alpha Levels in Hypertensive Patients with Metabolic Syndrome. METABOLIC SYNDROME AND RELATED DISORDERS , vol.17, no.3 , 167-172.

Kiyici, S., Guclu, M., BUDAK, F., SIĞIRLI, D., & Tuncel, E., (2019). Even Short-Term Telmisartan Treatment Ameliorated Insulin Resistance But Had No Influence on Serum Adiponectin and Tumor Necrosis Factor-Alpha Levels in Hypertensive Patients with Metabolic Syndrome. METABOLIC SYNDROME AND RELATED DISORDERS , vol.17, no.3, 167-172.

Kiyici, Sinem Et Al. "Even Short-Term Telmisartan Treatment Ameliorated Insulin Resistance But Had No Influence on Serum Adiponectin and Tumor Necrosis Factor-Alpha Levels in Hypertensive Patients with Metabolic Syndrome," METABOLIC SYNDROME AND RELATED DISORDERS , vol.17, no.3, 167-172, 2019

Kiyici, Sinem Et Al. "Even Short-Term Telmisartan Treatment Ameliorated Insulin Resistance But Had No Influence on Serum Adiponectin and Tumor Necrosis Factor-Alpha Levels in Hypertensive Patients with Metabolic Syndrome." METABOLIC SYNDROME AND RELATED DISORDERS , vol.17, no.3, pp.167-172, 2019

Kiyici, S. Et Al. (2019) . "Even Short-Term Telmisartan Treatment Ameliorated Insulin Resistance But Had No Influence on Serum Adiponectin and Tumor Necrosis Factor-Alpha Levels in Hypertensive Patients with Metabolic Syndrome." METABOLIC SYNDROME AND RELATED DISORDERS , vol.17, no.3, pp.167-172.

@article{article, author={Sinem Kiyici Et Al. }, title={Even Short-Term Telmisartan Treatment Ameliorated Insulin Resistance But Had No Influence on Serum Adiponectin and Tumor Necrosis Factor-Alpha Levels in Hypertensive Patients with Metabolic Syndrome}, journal={METABOLIC SYNDROME AND RELATED DISORDERS}, year=2019, pages={167-172} }